Article
Severe rhabdomyolysis associated with etoposide-nedaplatin chemotherapy in a patient with small cell lung cancer:case report and review of literature
2022-10-03
Abstract excerpt
Etoposide combined with platinum drugs is the first-line chemotherapy for small cell lung cancer(SCLC). Here, we describe the first case with small cell lung cancer, who developed severe rhabdomyolysis after etoposide-nedaplatin chemotherapy. He complained of progressive generalized muscle pain and weakness after first cycle chemotherapy for SCLC, accompanied by elevated creatine kinase (CK), myoglobin (Mb), alani...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 59963e6e-af9b-5d1b-b467-977907ba71b2
- DOI
- 10.22541/au.166479842.25115276/v1
